SCHEMBL3727933

SCHEMBL3727933

O=C1CC(COC(=O)c2ccccc2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.50
CARM1 Q86X55 1/20 0.50
PRMT6 Q96LA8 1/20 0.50
CHRNB2 P17787 1/20 0.49
CHRNA5 P30532 1/20 0.49
CHRNA7 P36544 1/20 0.49
CHRNA4 P43681 1/20 0.49
KMT2A Q03164 2/20 0.49
MAPK1 P28482 1/20 0.49
HIF1A Q16665 1/20 0.49
SLC6A2 P23975 1/20 0.49
SLC6A3 Q01959 1/20 0.49
LMNA P02545 2/20 0.47
ALDH1A1 P00352 1/20 0.47
CES2 O00748 1/20 0.47
DRD2 P14416 1/20 0.47
DRD4 P21917 1/20 0.47
PPM1B O75688 1/20 0.46
TSHR P16473 1/20 0.45
FOLH1 Q04609 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12439516 0.87 CARM1 (0.49) TDP1CARM1PRMT6CHRNB2CHRNA5
SCHEMBL8193371 0.86 CES2 (0.53) TDP1CARM1PRMT6CHRNB2CHRNA5
SCHEMBL8038485 0.85 CARM1 (0.49) TDP1CARM1PRMT6CHRNB2CHRNA5
SCHEMBL532785 0.84 CARM1 (0.61) TDP1CARM1PRMT6CHRNB2CHRNA5
SCHEMBL8447322 0.84 CARM1 (0.61) TDP1CARM1PRMT6CHRNB2CHRNA5
SCHEMBL8353672 0.83 TDP1 (0.56) TDP1KMT2AMAPK1HIF1ASLC6A2
SCHEMBL27872751 0.81 CARM1 (0.49) TDP1CARM1PRMT6CHRNB2CHRNA5
SCHEMBL25445958 0.81 CARM1 (0.58) TDP1CARM1PRMT6CHRNB2CHRNA5
SCHEMBL22005207 0.81 CARM1 (0.58) TDP1CARM1PRMT6CHRNB2CHRNA5
SCHEMBL1026556 0.81 TDP1 (0.52) TDP1CARM1PRMT6CHRNB2CHRNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825155-B2 Oxindole derivative as feeding control agent DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2010-11-02 US disclosed
US-20090131398-A1 OXINDOLE DERIVATIVE AS FEEDING CONTROL AGENT DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2009-05-21 US disclosed
EP-1935883-A1 OXINDOLE DERIVATIVE AS FEEDING CONTROL AGENT Dainippon Sumitomo Pharma Co., Ltd. (JP) 2008-06-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131398-A1 OXINDOLE DERIVATIVE AS FEEDING CONTROL AGENT GPR119, OXTR, CCKAR TDP1 4846/4885CARM1 410/4885PRMT6 53/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.